Andrius Žučenka, MD, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania, discusses the challenges and advancements in treating acute myeloid leukemia (AML) in patients who are unfit for intensive…
Cristina Papayannidis, MD, PhD, University of Bologna, Bologna, Italy, discusses a study evaluating the efficacy of combining venetoclax with hypomethylating agents in treating patients with acute myeloid leukemia…
Known as "xiao qiang" in China, or the "little mighty,” the American cockroach’s recent genome sequencing may help us understand how it earned that nickname.
Hepatitis C (HCV) infects an estimated 150 million people worldwide. It has proven to be a major cause of concern for medical professionals since it can also lead…
Professor Peter Jennings, BPharm, PhD, DSc, at Kings College of London discussed the most promising treatments out there right now for combating Parkinson’s. He discussed the condition to…
According to Lars Brouwers, MD, MSc, a physician and PhD-candidate performing research on 3D-printing in the hospital environment, when doctors use traditional x-ray and 2DCT diagnostic tools in…
Hepatitis C is an RNA flavivirus that infects 4 million people in the United States, making it the leading indicator for liver transplant in the US. It has…
Scientists take aim at developing a single therapeutic intervention to achieve sustained clotting factor levels adequate enough to prevent bleeding in patient with hemophilia B without needing to…
Deutetrabenazine, a novel VMAT-2 inhibitor, was evaluated in phase 3 trials for the treatment of tardive dyskinesia. The deuterated form of tetrabenazine was found to be well-tolerated, safe,…
